In non-IUGR pregnancies, CSH RNAi reduced uterine blood flow and the expression of endothelial nitric oxide synthase (NOS3) protein in caruncles, while increasing utero-placental glucose utilization [25]. The gene discussed is NOS3; the disease is fetal growth restriction.